Related Experiment Video
Updated: Dec 27, 2025

Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
The Phenoxyphenol Compound 4-HPPP Selectively Induces Antiproliferation Effects and Apoptosis in Human Lung Cancer
Wangta Liu1,2, Chang-Yi Wu1,3, Mei-Jei Lu1
1Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Abstract:
Lung cancer is a leading cause of cancer death worldwide, and non-small-cell lung cancer (NSCLC) accounts for 85% of lung cancer, which is highly metastatic, leading to the poor survival rate of patients. We recently reported that 4-[4-(4-hydroxyphenoxy)phenoxy]phenol (4-HPPP), a phenoxyphenol, exerts antihepatoma effects by inducing apoptosis and autophagy. In this study, we further examined the effect of 4-HPPP and its analogs on NSCLC cells. Colony formation assays showed that 4-HPPP exerts selective cytotoxicity against NSCLC H1299 cells; furthermore, the inhibitory effect of 4-HPPP on the proliferation and migration of NSCLC cells was validated using an in vivo zebrafish-based tumor xenograft assay. The flow cytometry-based dichlorofluorescein diacetate (DCF-DA) assays indicated that 4-HPPP caused an increase in reactive oxygen species (ROS) in NSCLC cells, and Western blot assays showed that the major ROS scavenging enzymes superoxide dismutases- (SODs-) 1/2 were upregulated, whereas peroxidase (PRX) was downregulated. Furthermore, 4-HPPP caused both aneuploidization and the accumulation of γH2AX, a sensor of DNA damage, as well as the activation of double-strand break (DSB) markers, especially Ataxia-telangiectasia-mutated and Rad3-related (ATR) in NSCLC cells. Our present work suggests that the antiproliferative effects of 4-HPPP on lung cancer cells could be due to its phenoxyphenol structure, and 4-HPPP could be a candidate molecule for treating NSCLC by modulating ROS levels and lowering the threshold of polyploidy-specific cell death in the future.
Insights
This study shows that 4-[4-(4-hydroxyphenoxy)phenoxy]phenol (4-HPPP) selectively kills non-small-cell lung cancer (NSCLC) cells by increasing reactive oxygen species (ROS) and DNA damage. 4-HPPP may be a potential new treatment for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Non-small-cell lung cancer (NSCLC) is a major cause of cancer mortality with poor patient survival rates.
- 4-[4-(4-hydroxyphenoxy)phenoxy]phenol (4-HPPP), a phenoxyphenol, has previously demonstrated anti-cancer effects in liver cancer cells.
Purpose of the Study:
- To investigate the anti-cancer effects of 4-HPPP and its analogs on NSCLC cells.
- To elucidate the mechanisms underlying 4-HPPP's action in NSCLC.
Main Methods:
- Colony formation assays and *in vivo* zebrafish xenograft models were used to assess cytotoxicity, proliferation, and migration.
- Flow cytometry (DCF-DA) and Western blotting were employed to analyze reactive oxygen species (ROS) levels and related enzyme expression.
- Analysis of DNA damage markers, including aneuploidization, *γ*H2AX, and double-strand break (DSB) pathway activation (ATR).
Main Results:
- 4-HPPP exhibited selective cytotoxicity against NSCLC H1299 cells, inhibiting proliferation and migration.
- 4-HPPP induced ROS production in NSCLC cells, with increased superoxide dismutases (SODs) 1/2 and decreased peroxidase (PRX).
- 4-HPPP caused DNA damage, evidenced by aneuploidization, *γ*H2AX accumulation, and activation of the ATR pathway.
Conclusions:
- The antiproliferative effects of 4-HPPP in NSCLC are linked to its phenoxyphenol structure.
- 4-HPPP demonstrates potential as a therapeutic candidate for NSCLC by modulating ROS and promoting polyploidy-specific cell death.
More Related Videos
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

